The relative isoform expression levels of isocitrate dehydrogenase in breast cancer: IDH2 is a potential target in MDA-MB-231 cells
Open Access
- 1 December 2023
- journal article
- research article
- Published by Korean Society of Clinical Oncology in Korean Journal of Clinical Oncology
- Vol. 19 (2) , 60-68
Abstract
Purpose: The isocitrate dehydrogenase (IDH) family plays an essential role in metabolism and energy production. The relative expression levels of IDH isoforms (IDH1, IDH2, and IDH3) have prognostic significance in several malignancies, including breast carcinoma. However, the IDH isozyme expression levels in different cancer stages and types have not been determined in breast carcinoma tissues.Methods: We analyzed the messenger RNA (mRNA) and protein levels of IDH (IDH1, IDH2, and IDH3A) and α-ketoglutarate (α-KG) in 59 breast carcinoma tissues.Results: The mRNA level of IDH2 was significantly increased at stages 2 and 3 in triple-negative and (ER-/PR-/HER+) breast cancers. However, the elevated α-KG level was only observed in stages 2 and 3, with no differences in the various breast carcinoma types. Western blotting analysis showed that IDH2 protein expression increased in the patient tissues and cell lines. An in vitro study showed IDH2 downregulation in the triple-negative breast cancer cell line MDA-MB-231 that inhibited cell proliferation and migration and induced cell cycle arrest in the G0/G1 phase.Conclusion: These findings suggest that different from IDH1 and IDH3, IDH2 is more highly expressed in stages 2 and 3 breast cancer tissues, especially in triple-negative breast cancer. IDH2 potentially serves as a target to detect unknown mechanisms in breast cancer.Keywords
Funding Information
- Chungnam National University
This publication has 16 references indexed in Scilit:
- Isocitrate dehydrogenase 1–snail axis dysfunction significantly correlates with breast cancer prognosis and regulates cell invasion abilityBreast Cancer Research, 2018
- Wild-type IDH2 promotes the Warburg effect and tumor growth through HIF1α in lung cancerTheranostics, 2018
- Isocitrate dehydrogenases in physiology and cancer: biochemical and molecular insightCell & Bioscience, 2017
- Aberrant IDH3α expression promotes malignant tumor growth by inducing HIF-1-mediated metabolic reprogramming and angiogenesisOncogene, 2014
- Isocitrate Dehydrogenase 1 (IDH1) Mutation in Breast Adenocarcinoma Is Associated With Elevated Levels of Serum and Urine 2-HydroxyglutarateThe Oncologist, 2014
- Breast CancerJAMA Surgery, 2013
- Altered expression levels of IDH2 are involved in the development of colon cancerExperimental and Therapeutic Medicine, 2012
- Quantitative proteome analysis of ovarian cancer tissues using a iTRAQ approachJournal of Cellular Biochemistry, 2012
- The Role of Mitochondrial NADPH-Dependent Isocitrate Dehydrogenase in Cancer CellsInternational Journal of Cell Biology, 2012
- Use of gene expression profiles to stage concurrent endometrioid tumors of the endometrium and ovaryGynecologic Oncology, 2008